Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma

NCT01583543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Ewing's Sarcoma

Interventions

DRUG: Olaparib

Sponsor

Massachusetts General Hospital